Patent · US Active

Means and methods for non-invasive diagnosis of chromosomal aneuploidy

US9784742B2 · kind B2 · utility

7Cited by

0References

9Claims

0Family size

Assignee

LifeCodexx AG · DE

Inventors

Marcus Benz · Konstanz, DE
Wera Hofmann · Konstanz, DE
Thomas Pohl · Holzgerlingen, DE
Christoph Von Kalle · Schallstadt, DE

Key dates

Filing date	Oct 26, 2010
Grant date	Oct 10, 2017
Priority date	—
Expiry date	Jun 9, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG16B30/00
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a prenatal diagnostic method for the determination of a fetal chromosomal aneuploidy in a biological sample obtained from a pregnant woman, which method comprises enrichment and quantification of selected cell-free deoxyribonucleic acid sequences showing consensus nucleosome binding regions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.